With regard to non-insulin therapy of type-2 diabetes, only one diabetes patient of the hyponatremia cohort was treated with incretin mimetics in addition to insulin, none was treated with sodium-glucose-transporter-2 inhibitors. This evidence concerns the gene INS and diabetes mellitus.